A new study from OHSU finds that the number of health care professionals able to write a prescription for buprenorphine, a key medication to treat addiction, quadrupled at community health clinics from 2016 to 2021. Daniel Hartung, Pharm.D., says, “There’s still a lot of work to be done. But it’s a step in the right direction when more providers have the capacity to write prescriptions to treat patients who want to be treated.”

A 2020 study led by OHSU on the benefits of patients stopping tobacco use during treatment.

a study that finds some differences in physical performance between transgender and cisgender athletes, using a quote from Joanna Harper, Ph.D., who says, “The idea that trans women are going to take over women’s sports is ludicrous,” and adds that blanket bans of transgender athletes are “unnecessary and unjustified.”

A study finds some differences in physical performance between transgender and cisgender athletes, using a quote from Joanna Harper, Ph.D., who says, “The idea that trans women are going to take over women’s sports is ludicrous,” and adds that blanket bans of transgender athletes are “unnecessary and unjustified.”

A new study from OHSU finds that the number of health care professionals able to write a prescription for buprenorphine, a key medication to treat addiction, quadrupled at community health clinics from 2016 to 2021. Daniel Hartung, Pharm.D., says, “There’s still a lot of work to be done. But it’s a step in the right direction when more providers have the capacity to write prescriptions to treat patients who want to be treated.”

The Portland Business Journal reports that Oregon has enjoyed an uptick in research grants and funding from the NIH, with OHSU remaining the top recipient.

A new study led by ZhenZhen Zhang, Ph.D., suggests women with breast cancer and germline BRCA pathogenic variants had increased all-cause mortality risk if their breast cancer diagnosis occurred within 10 years of giving birth. “Given that proximity to recent childbirth is such a strong factor associated with breast cancer metastasis and survival in the general population, the question of whether women with hereditary pathogenic variants in breast cancer predisposing genes have similarly poorer prognosis merits investigation,” Zhang says.

In a WebMD article about using a little-known blood test to manage cholesterol, P. Bart Duell, M.D., urges patients to get a blood test for Lp(a). “They should insist on having their Lp(a) level measured,” he says.

A new study led by ZhenZhen Zhang, Ph.D., suggests women with breast cancer and germline BRCA pathogenic variants had increased all-cause mortality risk if their breast cancer diagnosis occurred within 10 years of giving birth. “Given that proximity to recent childbirth is such a strong factor associated with breast cancer metastasis and survival in the general population, the question of whether women with hereditary pathogenic variants in breast cancer predisposing genes have similarly poorer prognosis merits investigation,” Zhang says.

A new study led by ZhenZhen Zhang, Ph.D., suggests women with breast cancer and germline BRCA pathogenic variants had increased all-cause mortality risk if their breast cancer diagnosis occurred within 10 years of giving birth. “Given that proximity to recent childbirth is such a strong factor associated with breast cancer metastasis and survival in the general population, the question of whether women with hereditary pathogenic variants in breast cancer predisposing genes have similarly poorer prognosis merits investigation,” Zhang says.